Global Rna Analysis Market

RNA Analysis Market Size, Share, Growth Analysis, By Technology(Real Time-PCR (qPCR) Technology, Microarray Technology), By Product(Instruments, Kits & Reagents), By Application(Construction of RNA Expression Atlas, Epigenetics) - Industry Forecast 2024-2031


Report ID: SQMIG35H2192 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 100 | Figures: 76

RNA Analysis Market Regional Insights

In the year 2022, North America secured the largest market share, encompassing 44.10% of the total. This dominance can be attributed to the swift evolution of structure-based drug designs, an escalating emphasis on transcriptomics research, and substantial investments in biopharmaceutical research and development. Moreover, the pronounced uptick in financial allocations for pharmaceutical exploration and drug innovation significantly propels revenue growth for companies operating within this region. This dynamic landscape is fueled by the convergence of research and development initiatives, culminating in an amplified market presence.

On the other hand, the Asia Pacific (APAC) region is poised to chart the swiftest CAGR during the forecast period, projected at 11.23%. This projection is underpinned by the escalating governmental and corporate investments catalyzing biotechnology research across APAC nations. Japan, in particular, boasts substantial governmental and non-governmental support for advancing biotech research, providing substantial funding in the medical and life sciences sectors. This nurturing environment emboldens researchers to proactively explore the realm of transcriptomics.

Furthermore, the APAC region's appeal is magnified by its reputation for cost-effective manufacturing services, attracting manufacturers to set their sights on this promising landscape. Strategic initiatives like partnerships also factor into the growth trajectory. Notably, in January 2020, Genetron Holdings Ltd. forged a strategic partnership with Thermo Fisher Scientific, a move aimed at extending precision cancer monitoring and diagnosis within China's public hospitals. These strategic collaborations augur well for the region's expansion, amplifying its capabilities and visibility on the global stage.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

RNA Analysis Market size was valued at USD 15.5 billion in 2022 and is poised to grow from USD 16.12 billion in 2023 to USD 22.06 billion by 2031, growing at a CAGR of 4.00% during the forecast period (2024-2031).

The competitive landscape of the RNA analysis market is characterized by intense rivalry among established players and innovative entrants, all striving to carve a niche in this rapidly evolving domain. Major companies such as Thermo Fisher Scientific, Illumina, Inc., Agilent Technologies, and Qiagen AG dominate the market with their extensive product portfolios, advanced RNA sequencing platforms, and robust bioinformatics solutions. 'Thermo Fisher Scientific Inc. (USA)', 'Illumina, Inc. (USA)', 'Agilent Technologies, Inc. (USA)', 'Qiagen AG (Germany)', 'PerkinElmer, Inc. (USA)', 'Eurofins Scientific SE (Luxembourg)', 'Genewiz (a Brooks Life Sciences Company) (USA)', 'Bio-Rad Laboratories, Inc. (USA)', 'Merck KGaA (Germany)', 'Promega Corporation (USA)', 'Fluidigm Corporation (USA)', 'Oxford Nanopore Technologies Ltd. (United Kingdom)', 'Takara Bio Inc. (Japan)', 'Zymo Research Corporation (USA)', 'BGI Group (China)', 'NuGEN Technologies, Inc. (USA)', 'Lexogen GmbH (Austria)', 'Pacific Biosciences of California, Inc. (USA)', 'Roche Diagnostics (Switzerland)', 'Bio-Techne Corporation (USA)'

The pharmaceutical and biotech sectors heavily rely on RNA analysis to develop targeted therapies, personalized medicine, and innovative drug candidates. This has fueled substantial demand for RNA analysis techniques.

Long Read Sequencing: Advances in long-read sequencing technologies are enabling the accurate sequencing of full-length RNA molecules, enhancing the understanding of alternative splicing, isoforms, and complex gene structures.

In the year 2022, North America secured the largest market share, encompassing 44.10% of the total. This dominance can be attributed to the swift evolution of structure-based drug designs, an escalating emphasis on transcriptomics research, and substantial investments in biopharmaceutical research and development. Moreover, the pronounced uptick in financial allocations for pharmaceutical exploration and drug innovation significantly propels revenue growth for companies operating within this region. This dynamic landscape is fueled by the convergence of research and development initiatives, culminating in an amplified market presence.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Rna Analysis Market

Product ID: SQMIG35H2192

$5,300
BUY NOW GET FREE SAMPLE